F5 Quote - FFV | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Germany
TG
F5 Inc (FFV) Share Price

F5 Inc (FFV)

251.20

3.40

( 1.37% )

Updated: 06:24:07

Realtime Data

Professional-Grade Tools, for Individual Investors.

Current Price

251.20

Bid

249.00

Offer

250.20

Volume

17

248.10 Day's Range 251.20

149.75 52 Week Range 251.20

Market Cap

Previous Close

247.80

Open

248.10

Last Trade

Last Trade Time

03:26:00

Financial Volume

-

VWAP

-

Average Volume (3m)

88

Shares Outstanding

58,614,865

Dividend Yield

-

PE Ratio

27.14

Earnings Per Share (EPS)

9.67

Revenue

2.82B

Net Profit

566.78M

Sector

Computer Communication Equip

Industry

Computer Communication Equip

Website

www.f5.com

Headquarters

Olympia, Washington, USA

Founded

-

F5 Inc is listed in the Computer Communication Equip sector of the Tradegate (DE) with ticker FFV. The last closing price for F5 was 247.80 €. Over the last year, F5 shares have traded in a share price range of 149.75 € to 251.20 €.

F5 currently has 58,614,865 shares in issue. The market capitalisation of F5 is 14.52 € billion. F5 has a price to earnings ratio (PE ratio) of 27.14.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	9.3	3.84456386937	241.9	251.2	239.9	42	244.49230769	DE
4	18.5	7.95015040825	232.7	251.2	224.3	66	235.09253956	DE
12	56.85	29.251350656	194.35	251.2	193	88	216.92715199	DE
26	94.4	60.2040816327	156.8	251.2	154.5	104	193.18100086	DE
52	90.2	56.0248447205	161	251.2	149.75	94	181.19279382	DE
156	47.9	23.5612395475	203.3	251.2	137.44999	62	177.54710202	DE
260	127.2	102.580645161	124	251.2	81	42	169.13038955	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
R1EAEV Resources Ltd	0.0022 € (83.33%)	796.77k
AXIAtos SE	0.003 € (76.47%)	1.88B
CSVCorporacion Financiera Alba	80.10 € (69.70%)	9.1k
4GBGossamer Bio Inc	0.9545 € (39.85%)	8.07k
1W81WISeKey International Holding Ltd	3.20 € (39.13%)	1.95k
LL3PanGenomic Health Inc	0.0895 € (-56.08%)	300
EJ7Energy Resources of Australia	0.001 € (-50.00%)	591k
8BTBriaCell Therapeutics Corp	0.62 € (-40.95%)	3.93k
CB82Gratomic Inc	0.019 € (-40.63%)	20k
D0TLegible Inc	0.026 € (-33.33%)	100k
AXIAtos SE	0.003 € (76.47%)	1.88B
D7GNel ASA	0.2721 € (-2.30%)	4.78M
TUI1Tui AG	8.596 € (-0.65%)	2.49M
PF8European Lithium Limited	0.0226 € (-13.08%)	1.71M
34Q0Quantum eMotion Inc	0.204 € (-20.93%)	1.35M

fliegenfranz1

fliegenfranz1 5 minutes ago

train21

train21 5 minutes ago

I know but I don't trust him over a private sale

OrbitWitch50

OrbitWitch50 5 minutes ago

The way this moves should be a flippers paradise. Not encouraging it but accepting it.

rheddle

rheddle 5 minutes ago

It's about 700M dilution between beginning of August 2024 and December 11th.

The Sheikh is real. If you look at James Thorpe's linkedin (CFO) there are photos of him going back 5 years with Al Thani. More recent photos in Qatar with that guy Miro who seems to be out as of December (pe

pitcook

pitcook 5 minutes ago

How many $billions are our patents worth now?

cableguy

cableguy 6 minutes ago

Yes Thanks, much appreciated, ASII

BearRickPunch

BearRickPunch 6 minutes ago

It isn't shorted. It's a grey market ticker and it's a lame or lazy argument to say so conveniently that "FINRA doesn’t report shorting and or naked shorting in Canada". FINRA reports all shorting and they obviously don't report shorting for ERHE because it isn't being shorted.

Brocool

Brocool 6 minutes ago

Kronos announced the formation of Atomiq, Inc., a new subsidiary focused on nuclear battery technology development.$KNOS

MartinLutherKing

MartinLutherKing 6 minutes ago

What’s the float with this piece of garbage

Monksdream

Monksdream 6 minutes ago

Short positions do represent potential buying power

Minddoc7

Minddoc7 7 minutes ago

So now you're buying gold when it's approaching $3000. Great timing! I've been in gold & precious metals since 1999 when gold was $400. Thanks, but I don't believe I'll follow your investment advise.

Basilisk

Basilisk 7 minutes ago

Wouldn't that require something more that $6 billion in new capital beyond the current market cap? Who would provide that? I'm not confidant retail buyers have that amount of ready capital or would spend it in the absence of demonstrated revenue. And then there are the MM machinations That amount of

starkd748

starkd748 7 minutes ago

I put most my crypto on tangem cold storage...

JusDePomme

JusDePomme 7 minutes ago

HMBL break .0011 coming up

Monksdream

Monksdream 7 minutes ago

NIXX, uptrend
https://investorshub.advfn.com/uimage/uploads/2024/12/12/ervhxIMG_3878.gif

Buckey

Buckey 8 minutes ago

SFHG down 62% to 1.19 after big tank yesterday - Gotta think sub dollar on the table soon

janga

janga 8 minutes ago

If there’s 15-million on the Ask So why don’t one of those 15-million Bid knock it off because if news drops everybody will be out of luck and right now you can get the whole thing in one place: you’re worrying about a one or two points click when price is looking at fifteen cents or more; Greed

stressfreeliving

stressfreeliving 8 minutes ago

So much more trading volume is needed.

100 of millions will need to be up on L2.

Biowatch

Biowatch 9 minutes ago

Crown commences RVNC tender offer at $3.10

[Crown] today announced that it has commenced a cash tender offer to acquire all outstanding shares of common stock of Revance Therapeutics, Inc., ("Revance") (Nasdaq: RVNC) at a price of $3.10 per share in cash. The tender offer is being mad

Brocool

Brocool 9 minutes ago

Kronos announced the formation of Atomiq, Inc., a new subsidiary focused on nuclear battery technology development. $KNOS

PonkenPlonken

PonkenPlonken 9 minutes ago

I always interpet them as to-be-buyers too.

just Scottie

just Scottie 9 minutes ago

I hope he sees your posts and does it lol

elijah17

elijah17 9 minutes ago

HOW long will muerda stay 2.45

janice shell

janice shell 9 minutes ago

Merry Christmas!

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions